Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA name
hsa-miR-624-3p
Specific or universal ncRNAs
Specific ncRNAs
Class
MicroRNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
ARRDC3/YAP/HIF1Ī±
Cancer name
Esophageal Squamous Cell Carcinoma
Cancer site
qRT-PCR,Western blot,Dual-luciferase assay
Treatment type
Chemotherapy
Drug
Cisplatin/Paclitaxel
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
MicroRNA-624-mediated ARRDC3/YAP/HIF1Ī± axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel
Tissue resource
esophageal squamous cell carcinoma cell lines KYSE150
esophageal squamous cell carcinoma cell lines KYSE450
esophageal squamous cell carcinoma cell lines KYSE410
esophageal squamous cell carcinoma cell lines KYSE510
Experiment
None
Institute
Roswell Park Memorial Institute
Country
Continent
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.